EX-99.1 3 dex991.htm REVISED SELECTED FINANCIAL DATA AND REVISED CONSOLIDATED FINANCIAL STATEMENTS Revised Selected Financial Data and Revised Consolidated Financial Statements

EXHIBIT 99.1

 

Item 6. Selected Financial Data

This information should be read in conjunction with our consolidated financial statements and notes thereto.

 

     Fiscal Year Ended  
     2008     2007     2006     2005     2004  
     (in thousands, except per share data)  

Statement of Operations Data:

          

Revenues:

          

Net product revenues

   $ 107,582      $ 94,191      $ 65,902      $ 85,247      $ 85,213   

Research and development revenues

     7,223        3,958        5,189        5,049        2,068   
                                        

Total revenues

     114,805        98,149        71,091        90,296        87,281   

Expenses:

          

Cost of product revenues

     77,980        78,625        49,293        54,970        73,182   

Research and development—funded programs

     5,076        3,157        4,908        6,498        2,340   

Research and development—internal

     10,898        8,300        5,341        5,766        12,693   

Selling, general and administrative

     15,980        18,009        19,317        14,114        10,141   

Other

     —          —          —          —          240   

Impairment charges(1)

     —          —          —          518        5,323   
                                        
     109,934        108,091        78,859        81,866        103,919   
                                        

Income (loss) from operations

     4,871        (9,942     (7,768     8,430        (16,638

Other income and expense:

          

Interest income

     3,281        4,451        4,786        3,596        2,821   

Other income

     93        85        468        76        178   

Impairment on loan to unconsolidated affiliate

     (1,188     —          —          —          —     

Loss on sale of Kenet

     (2,691     —          —          —          —     

Impairment of marketable debt securities

     (1,252     —          —          —          —     

Other-than-temporary impairment of Micrel common stock

     (224     (123     —          —          —     

Gain on sale of Micrel common stock

     —          —          1,208        —          —     

Foreign currency transaction gains (losses)

     2,296        93        (773     (226     (1,009

Interest and other expense

     (44     (68     (56     (122     (70
                                        
     271        4,438        5,633        3,324        1,920   
                                        

Income (loss) before (provision) benefit from income taxes, equity losses in unconsolidated affiliates, cumulative effect of accounting change and net (income) loss of noncontrolling interest

     5,142        (5,504     (2,135     11,754        (14,718

Tax (provision) benefit

     (792     (465     273        (162     330   
                                        

Income (loss) before equity losses in unconsolidated affiliates, cumulative effect of accounting change and net (income) loss of noncontrolling interest

     4,350        (5,969     (1,862     11,592        (14,388

Equity losses in unconsolidated affiliates

     (1,081     (275     (594     (210     (879
                                        

Income (loss) before cumulative effect of accounting change and net (income) loss of noncontrolling interest

     3,269        (6,244     (2,456     11,382        (15,267

Cumulative effect of accounting change(2)

     —          —          —          (443     —     
                                        

Net income (loss)

   $ 3,269      $ (6,244   $ (2,456   $ 10,939      $ (15,267
                                        

Net (income) loss attributable to the noncontrolling interest

     (683     (312     307        (435     (106

Net income (loss) attributable to the controlling interest

   $ 2,586      $ (6,556   $ (2,149   $ 10,504      $ (15,373
                                        

Income (loss) before cumulative effect of accounting change per share:

          

Basic

   $ 0.04      $ (0.10   $ (0.03   $ 0.16      $ (0.22

Diluted

   $ 0.04      $ (0.10   $ (0.03   $ 0.16      $ (0.22

Cumulative effect of accounting change per share:

          

Basic

   $ —        $ —        $ —        $ (0.01   $ —     

Diluted

   $ —        $ —        $ —        $ (0.01   $ —     

Net income (loss) per share:

          

Basic

   $ 0.04      $ (0.10   $ (0.03   $ 0.15      $ (0.22

Diluted

   $ 0.04      $ (0.10   $ (0.03   $ 0.15      $ (0.22

Weighted average number of common shares outstanding:

          

Basic

     67,876        67,544        68,064        69,334        70,052   

Diluted

     68,164        67,544        68,064        69,879        70,052   

 

     Fiscal Year Ended
     2008    2007    2006    2005    2004

Balance Sheet Data:

              

Cash and cash equivalents and marketable debt securities

   100,016    93,304    105,360    119,757    111,900

Working capital

   116,841    107,931    116,119    128,950    123,509

Total assets

   159,677    161,054    161,413    166,334    156,452

Long-term obligations

   867    806    772    740    —  

Total stockholders’ equity

   138,482    137,484    140,965    146,275    139,419

 

(1) The Company recorded a $0.5 million and a $5.3 million impairment charge in fiscal year 2005 and 2004, respectively, as a result of its discontinuance of CyberLite LED manufacturing and development activities.
(2) The Company adopted Financial Accounting Standards Board (FASB) Interpretation No. 47, “Accounting for Conditional Asset Retirement Obligations—an interpretation of FASB Statement No. 143,” in 2005.


Item 8. Financial Statements and Supplementary Data

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Stockholders of

Kopin Corporation

Taunton, Massachusetts

We have audited the accompanying consolidated balance sheets of Kopin Corporation and subsidiaries (the “Company”) as of December 27, 2008 and December 29, 2007, and the related consolidated statements of operations, comprehensive loss, stockholders’ equity, and cash flows for each of the three years in the period ended December 27, 2008. Our audits also included the financial statement schedule listed in the Index of the Company’s Annual Report on Form 10-K at Item 15(a)(2). These financial statements and financial statement schedule are the responsibility of the Company’s management. Our responsibility is to express an opinion on the financial statements and financial statement schedule based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, such consolidated financial statements present fairly, in all material respects, the financial position of Kopin Corporation and subsidiaries as of December 27, 2008 and December 29, 2007, and the results of their operations and their cash flows for each of the three years in the period ended December 27, 2008, in conformity with accounting principles generally accepted in the United States of America. Also, in our opinion, such financial statement schedule, when considered in relation to the basic consolidated financial statements taken as a whole, present fairly, in all material respects, the information set forth therein.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the Company’s internal control over financial reporting as of December 27, 2008, based on the criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated March 10, 2009 (not included herein) expressed an unqualified opinion on the Company’s internal control over financial reporting.

/s/ DELOITTE & TOUCHE LLP

Boston, Massachusetts

March 10, 2009 (November 19, 2009 as to the effects of the retrospective adoption of Financial Accounting Standards Board Statement No. 160 as described in Note 1 to the financial statements)


KOPIN CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

 

     December 27,
2008
    December 29,
2007
 

ASSETS

    

Current assets:

    

Cash and equivalents

   $ 57,949,449      $ 30,748,060   

Marketable securities, at fair value

     42,066,542        62,556,257   

Accounts receivable, net of allowance of $664,000 and $708,000 in 2008 and 2007 respectively

     14,394,306        10,600,794   

Accounts receivable from unconsolidated affiliates, net of allowance of $507,000 in 2008

     2,814,447        3,621,463   

Unbilled receivables

     2,395,963        905,151   

Inventory

     13,269,486        16,732,060   

Prepaid taxes

     206,471        874,807   

Prepaid expenses and other current assets

     1,160,497        1,107,151   
                

Total current assets

     134,257,161        127,145,743   

Property, plant and equipment

     19,359,874        21,927,061   

Other assets

     6,060,460        11,981,173   
                

Total assets

   $ 159,677,495      $ 161,053,977   
                

LIABILITIES AND STOCKHOLDERS’ EQUITY

    

Current liabilities:

    

Accounts payable

   $ 7,744,005      $ 10,295,340   

Accounts payable to unconsolidated affiliates

     992,990        2,084,491   

Accrued payroll and expenses

     2,304,210        2,926,176   

Accrued warranty

     1,250,000        1,030,000   

Billings in excess of revenue earned

     3,127,923        173,851   

Other accrued liabilities and professional fees

     1,996,947        2,704,544   
                

Total current liabilities

     17,416,075        19,214,402   

Asset retirement obligations

     866,965        805,797   

Commitments and contingencies

    

Stockholders’ equity:

    

Preferred stock, par value $.01 per share: authorized, 3,000 shares; none issued

     —          —     

Common stock, par value $.01 per share: authorized, 120,000,000 shares; issued 73,147,743 shares in 2008 and 71,935,976 in 2007; outstanding 68,257,748 in 2008 and 67,741,956 in 2007

     718,732        713,574   

Additional paid-in capital

     310,241,805        307,900,357   

Treasury stock (3,615,480 shares in 2008 and 2007, at cost)

     (14,552,865     (14,552,865

Accumulated other comprehensive (loss) income

     (168,303     3,767,256   

Accumulated deficit

     (157,757,433     (160,343,913
                

Total Kopin Corporation stockholders’ equity

     138,481,936        137,484,409   

Noncontrolling interest

     2,912,519        3,549,369   
                

Total stockholders’ equity

     141,394,455        141,033,778   
                

Total liabilities and stockholders’ equity

   $ 159,677,495      $ 161,053,977   
                


KOPIN CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

Fiscal Year Ended

   2008     2007     2006  

Revenues:

      

Net product revenues

   $ 107,581,841      $ 94,191,465      $ 65,902,228   

Research and development revenues

     7,223,696        3,957,648        5,189,128   
                        
     114,805,537        98,149,113        71,091,356   

Expenses:

      

Cost of product revenues

     77,979,570        78,624,626        49,292,767   

Research and development-funded programs

     5,075,774        3,157,452        4,907,836   

Research and development-internal

     10,898,268        8,300,285        5,340,686   

Selling, general, and administration

     15,980,362        18,008,967        19,317,791   
                        
     109,933,974        108,091,330        78,859,080   

Income (loss) from operations

     4,871,563        (9,942,217     (7,767,724

Other income and expense:

      

Interest income

     3,281,297        4,450,623        4,785,987   

Other income

     92,872        85,317        468,498   

Impairment on loans to unconsolidated affiliate

     (1,187,937     —          —     

Loss on sale of Kenet

     (2,690,645     —          —     

Other-than temporary impairment of marketable debt securities

     (1,252,342     —          —     

Other-than temporary impairment of Micrel common stock

     (224,280     (123,253     —     

Gain on sale of Micrel common stock

     —          —          1,208,000   

Foreign currency transaction gains (losses)

     2,296,222        93,347        (773,203

Interest and other expense

     (43,912     (68,007     (56,664
                        
     271,275        4,438,027        5,632,618   
                        

Income (loss) before (provision) benefit for income taxes, equity losses in unconsolidated affiliates and net (income) loss of noncontrolling interest

     5,142,838        (5,504,190     (2,135,106

Tax (provision) benefit

     (792,000     (465,000     273,000   
                        

Income (loss) before equity losses in unconsolidated affiliates and net (income) loss of noncontrolling interest

     4,350,838        (5,969,190     (1,862,106

Equity losses in unconsolidated affiliates

     (1,081,205     (274,577     (593,911
                        

Net income (loss)

     3,269,633        (6,243,767     (2,456,017

Net (income) loss attributable to the noncontrolling interest

     (683,153     (312,333     306,543   
                        

Net income (loss) attributable to the controlling interest

   $ 2,586,480      $ (6,556,100   $ (2,149,474
                        

Net income (loss) per share:

      

Basic

   $ 0.04      $ (0.10   $ (0.03
                        

Diluted

   $ 0.04      $ (0.10   $ (0.03
                        

Weighted average number of common shares outstanding:

      

Basic

     67,876,385        67,543,957        68,064,262   
                        

Diluted

     68,163,759        67,543,957        68,064,262   
                        


KOPIN CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

 

Fiscal Year Ended

   2008     2007     2006  

Net income (loss)

   $ 3,269,633      $ (6,243,767   $ (2,456,017

Foreign currency translation adjustments

     (6,055,056     49,256        1,590,863   

Unrealized holding gain on marketable securities

     853,808        679,702        74,964   

Reclassifications of gains in net income (loss)

     (54,313     (147,370     (416,593
                        

Comprehensive loss

     (1,985,928     (5,662,179     (1,206,783

Comprehensive income (loss) attributable to the noncontrolling interest

     636,849        (71,763     (119,834
                        

Comprehensive loss attributable to Kopin Corporation

   $ (1,349,079   $ (5,733,942   $ (1,326,617
                        


KOPIN CORPORATION

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

 

                 Additional
Paid-in
Capital
    Deferred
Compensation
  Treasury
Stock
    Accumulated
Other
Comprehensive
Income (Loss)
    Accumulated
Deficit
    Total Kopin
Corporation
Stockholders’
Equity
    Noncontrolling
Interest
    Total
Stockholders’
Equity
 
                   
  Common Stock                  
  Shares     Amount                  

Balance, December 31, 2005

  71,235,036      $  712,350      $  305,166,998      $  (2,689,048)   $  (7,398,868)      $  2,122,241      $ (151,638,339   $  146,275,334      $  4,337,925      $  150,613,259   

Exercise of stock options

  161,925        1,619        518,828        —       —          —          —          520,447        —          520,447   

Change in accounting for stock compensation

  (286,500     (2,865     (2,686,183     2,689,048     —          —          —          —          —          —     

Stock based compensation expense

  —          —          2,789,658        —       —          —          —          2,789,658        —          2,789,658   

Forfeiture of nonvested stock

  (26,750     (267     267        —       —          —          —          —          —          —     

Net unrealized holding loss on marketable securities

  —          —          —          —       —          (341,629     —          (341,629     —          (341,629

Foreign currency translation adjustments

  —          —          —          —       —          1,164,486        —          1,164,486        426,342        1,590,828   

Restricted stock for tax withholding obligations

  (40,320     (403     (139,525     —       (220,098     —          —          (360,026     —          (360,026

Treasury stock purchase

  —          —          —          —       (6,933,899     —          —          (6,933,899     —          (6,933,899

Net loss

  —          —          —          —       —          —          (2,149,474     (2,149,474     (306,543     (2,456,017
                                                                           

Balance, December 30, 2006

  71,043,391      $ 710,434      $ 305,650,043      $ —     $ (14,552,865   $ 2,945,098      $ (153,787,813   $ 140,964,897      $ 4,457,724      $ 145,422,621   
                                                                           

Exercise of stock options

  95,849        958        278,920        —       —          —          —          279,878        —          279,878   

Stock based compensation expense

  —          —          2,254,556        —       —          —          —          2,254,556        —          2,254,556   

Vesting of restricted stock

  301,313        3,013        (3,013     —       —          —          —          —          —          —     

Net unrealized holding gain on marketable securities

  —          —          —          —       —          532,332        —          532,332        —          532,332   

Foreign currency translation adjustments

  —          —          —          —       —          289,826        —          289,826        (240,570     49,256   

Restricted stock for tax withholding obligations

  (83,089     (831     (280,149     —       —          —          —          (280,980     —          (280,980

Kopin additional investment

  —          —          —          —       —          —          —          —          (980,118     (980,118

Net (loss) income

  —          —          —          —       —          —          (6,556,100     (6,556,100     312,333        (6,243,767
                                                                           

Balance, December 29, 2007

  71,357,464      $ 713,574      $ 307,900,357      $ —     $ (14,552,865   $ 3,767,256      $ (160,343,913   $ 137,484,409      $ 3,549,369      $ 141,033,778   
                                                                           

Exercise of stock options

  44,053        441        131,045        —       —          —          —          131,486        —          131,486   

Stock based compensation expense

  —          —          2,740,849        —       —          —          —          2,740,849        —          2,740,849   

Vesting of restricted stock

  633,571        6,336        (6,336     —       —          —          —          —          —          —     

Net unrealized holding gain on marketable securities

  —          —          —          —       —          799,495        —          799,495        —          799,495   

Foreign currency translation adjustments

  —          —          —          —       —          (4,735,054     —          (4,735,054     (1,320,003     (6,055,057

Restricted stock for tax withholding obligations

  (161,860     (1,619     (345,372     —       —          —          —          (346,991     —          (346,991

Stock option tender offer

  —          —          (178,738     —       —          —          —          (178,738     —          (178,738

Net income

  —          —          —          —       —          —          2,586,480        2,586,480        683,153        3,269,633   
                                                                           

Balance, December 27, 2008

  71,873,228      $ 718,732      $ 310,241,805      $ —     $ (14,552,865   $ (168,303   $ (157,757,433   $ 138,481,936      $ 2,912,519      $ 141,394,455   
                                                                           

 


KOPIN CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

Fiscal year ended

   2008     2007     2006  

Cash flows from operating activities:

      

Net income (loss)

   $ 3,269,633      $ (6,243,767   $ (2,456,017

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

      

Depreciation

     5,035,403        3,457,020        2,623,283   

Amortization (accretion) of premium or discount on marketable debt securities

     146,614        225,773        236,076   

Loss on disposal of equipment

     —          453,050        —     

Stock-based compensation

     2,740,849        2,254,557        2,789,658   

Net gain on investment transactions

     —          —          (1,208,000

Equity losses in unconsolidated affiliates

     1,081,205        274,577        593,911   

Impairment on marketable debt securities

     1,476,622        123,253        —     

Loss on disposal of unconsolidated affiliate

     2,690,645        —          —     

Loan loss reserve unconsolidated affiliate

     1,187,937        —          —     

Foreign currency gains

     (2,296,222     —          —     

Change in allowance for bad debt

     463,000        480,000        (53,000

Change in other non-cash items

     (105,682     —          (446,094

Changes in assets and liabilities:

      

Accounts receivable

     (8,259,245     (3,641,220     964,085   

Inventory

     3,192,566        (4,880,725     (2,235,270

Deferred tax asset

     —          —          370,000   

Prepaid expenses and other current assets

     423,706        163,398        232,400   

Accounts payable and accrued expenses

     (2,330,171     3,188,900        399,812   

Billings in excess of revenue earned

     2,954,072        14,584        (921,543
                        

Net cash provided by (used in) operating activities

     11,670,932        (4,130,600     889,301   
                        

Cash flows from investing activities:

      

Proceeds from sale of marketable securities

     51,521,564        32,020,156        43,449,627   

Purchase of marketable securities

     (31,631,309     (16,451,503     (32,538,083

Other assets

     36,371        (23,325     47,189   

Proceeds from sale of investments

     2,705,260        —          3,002,000   

Proceeds from insurance

     —          —          33,000   

Investment in Kowon

     —          (980,118     —     

Investments in equity and cost based affiliates

     —          —          (4,952,063

Loans to unconsolidated affiliate

     (2,012,213     —          —     

Capital expenditures

     (3,334,079     (7,637,451     (7,867,729
                        

Net cash provided by investing activities

     17,285,594        6,927,759        1,173,941   

Cash flows from financing activities:

      

Treasury stock purchases

     —          —          (6,933,899

Settlements of restricted stock for tax withholding obligations

     (346,991     (280,980     (360,023

Proceeds from exercise of stock options

     131,485        279,878        520,446   
                        

Net cash used in financing activities

     (215,506     (1,102     (6,773,476

Effect of exchange rate changes on cash

     (1,539,631     44,347        1,115,245   
                        

Net increase (decrease) in cash and equivalents

     27,201,389        2,840,404        (3,594,989

Cash and equivalents:

      

Beginning of period

     30,748,060        27,907,656        31,502,645   
                        

End of period

   $ 57,949,449      $ 30,748,060      $ 27,907,656   
                        

Supplemental disclosure of cash flow information:

      

Income taxes paid

   $ 238,000      $ 93,000      $ 834,000   
                        

Supplemental schedule of noncash investing activities:

      

Construction in progress included in accrued expenses

   $ 258,804      $ 810,469      $ 602,892   
                        


KOPIN CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

1. Summary of Significant Accounting Policies

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Fiscal Year

The Company’s fiscal year ends on the last Saturday in December. The fiscal years ended December 27, 2008, December 29, 2007 and December 30, 2006 each include 52 weeks and are referred to as fiscal years 2008, 2007 and 2006, respectively, herein.

Principles of Consolidation

The consolidated financial statements include the accounts of the Company, its wholly owned subsidiaries and Kowon Technology Co., Ltd. (Kowon), a majority owned (78%) subsidiary located in Korea. All inter-company transactions and balances have been eliminated. The noncontrolling interest in earnings of Kowon is reflected separately in the consolidated statements of operations. Investment in business entities in which the Company does not have control, but has the ability to exercise significant influence over operating and financial policies (generally 20-50 percent ownership interest in common stock), are accounted for by the equity method.

Revenue Recognition

The Company recognizes revenue in accordance with Securities and Exchange Commission (SEC) Staff Accounting Bulletin No. 104, Revenue Recognition (SAB 104). SAB 104 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred and services rendered; (3) the price to the buyer is fixed or determinable; and (4) collectability is reasonably assured. The Company does not recognize revenue for products prior to customer acceptance unless it believes the product meets all customer specifications and the Company has a history of consistently achieving customer acceptance of the product. Provisions for product returns and allowances are recorded in the same period as the related revenues. The Company analyzes historical returns, current economic trends and changes in customer demand and acceptance of product when evaluating the adequacy of sales returns and other allowances. Certain product sales are made to distributors under agreements allowing for a limited right of return on unsold products. Sales to distributors are primarily made for sales to the distributor’s customers and not for their stocking of inventory. The Company delays revenue recognition for its estimate of distributor claims of right of return on unsold products based upon its historical experience with the Company’s products and specific analysis of amounts subject to return based upon discussions with the Company’s distributors or their customers.

The Company recognizes revenues from long-term research and development contracts on the percentage-of-completion method of accounting as work is performed, based upon the ratio of costs or hours already incurred to the estimated total cost of completion or hours of work to be performed. Revenue recognized at any point in time is limited to the amount funded by the U.S. government or contracting entity. The Company accounts for product development and research contracts that have established prices for distinct phases as if each phase were a separate contract. In some instances, the Company is contracted to create a deliverable which is anticipated to be qualified and go into full rate production stages. In those cases, the revenue recognition methodology will change from the percentage of completion method to the units-of-delivery method as new contracts are received after formal qualification has been completed. In certain instances qualification may be achieved and delivery of production units may commence however the Company’s customer may have either identified new issues to be resolved or wish to incorporate a newer display technology. In these circumstances new units delivered will continue to be accounted for under the units-of –delivery method.

The Company classifies amounts earned on contracts in progress that are in excess of amounts billed as unbilled receivables and classifies amounts received in excess of amounts earned as billings in excess of revenues earned. The Company invoices based on dates specified in the related agreement or in periodic installments based upon its invoicing cycle. The Company recognizes the entire amount of an estimated ultimate loss in its financial statements at the time the loss on a contract becomes known.

Research and Development Costs

Research and development expenses are incurred in support of internal display and III-V product development programs or programs funded by agencies or prime contractors of the U.S. government, the KoBrite joint venture and commercial partners. Research and development costs include staffing, purchases of materials and laboratory supplies, circuit design costs, fabrication and packaging of experimental display products, and overhead, and are expensed immediately.


KOPIN CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

Cash and Equivalents and Marketable Securities

The Company considers all highly liquid, short-term debt instruments with original maturities of three months or less to be cash equivalents.

Marketable debt securities consist primarily of commercial paper, medium-term corporate notes, and United States government and agency backed securities. The Company classifies marketable debt securities included in “Marketable Securities” and the investment in Micrel in “Other Assets” as available-for-sale and accordingly carries them at fair value. The net unrealized holding gains (losses), recorded in accumulated other comprehensive income (loss), for available-for-sale marketable debt securities at December 27, 2008, December 29, 2007 and December 30, 2006, were $558,381, ($201,716) and ($1,099,762), respectively. The Company records the amortization of premium and accretion of discounts on marketable debt securities in the results of operations.

Investments in available-for-sale marketable debt securities are as follows at December 27, 2008 and December 29, 2007:

 

     Amortized Cost    Unrealized Gains    Unrealized Losses    Fair Value
     2008    2007    2008    2007    2008    2007    2008    2007

U.S. government and agency backed securities

   $ 25,353,439    $ 41,438,125    $ 533,923    $ 76,620    $ —      $ —      $ 25,887,362    $ 41,514,745

Corporate debt

     16,154,722      21,319,847      24,458      —        —        278,335      16,179,180      21,041,512
                                                       

Total

   $ 41,508,161    $ 62,757,972    $ 558,381    $ 76,620    $ —      $ 278,335    $ 42,066,542    $ 62,556,257
                                                       

The contractual maturity of the Company’s marketable debt securities is as follows at December 27, 2008:

 

     Less than
One year
   One to
Five years
   Greater than
Five years
   Total

U.S. government and agency backed securities

   $ 4,110,540    $ 21,776,822    $ —      $ 25,887,362

Corporate debt

     —        6,450,930      9,728,250      16,179,180
                           

Total

   $ 4,110,540    $ 28,227,752    $ 9,728,250    $ 42,066,542
                           

The Company uses the specific identification method as a basis for determining cost and calculating realized gains and losses. The gross gains and losses realized related to sales of marketable debt securities were not material during fiscal years 2008, 2007 and 2006.

Included in Other Income and Expense is an impairment charge on investments in corporate debt instruments of $1.3 million. The corporate debt consists of Floating Rate Notes with a maturity that is over multiple years but has interest rates which are reset every three months based on then current three month London Interbank Offering Rate (3 month Libor). The Company determines the fair market values of these corporate debt instruments through the use of a model which incorporates the 3 month Libor and the credit default swap rate of the issuer. After the fair market value of these corporate debt instruments is computed under this method it is compared to the bid and ask price spread of same or similar investments which are traded on several markets. The bid and ask prices for the corporate debt instruments are not the sole input in determining the fair market value of the instruments because the spreads between the bid and ask prices have been increasing, which indicates that they may not reflect an accurate measure of fair market value. The impairment of $1.3 million represents the difference between the acquisition cost of the corporate debt instrument and the computation of the fair market value of the investments for all corporate debt instruments whose acquisition cost has exceeded their computed fair market value for 12 months.

Inventory

Inventory is stated at the lower of cost (determined on the first-in, first-out or specific identification method) or market and consists of the following at December 27, 2008 and December 29, 2007:

 

     2008    2007

Raw materials

   $ 7,679,199    $ 9,463,478

Work-in-process

     2,505,113      3,447,661

Finished goods

     3,085,174      3,820,921
             
   $ 13,269,486    $ 16,732,060
             

Inventory on consignment at customer locations was $2.3 million and $3.7 million at December 27, 2008 and December 29, 2007, respectively.


KOPIN CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

Property, plant and equipment

Property, plant and equipment are recorded at cost. Depreciation and amortization are provided using the straight-line method over the estimated useful lives of the assets, generally 3 to 10 years. Leasehold improvements and leased equipment are amortized over the shorter of the term of the lease or the useful life of the improvement or equipment. As discussed below, obligations for asset retirement are accrued at the time property, plant and equipment is initially purchased or as such obligations are generated from use.

Product Warranty

The Company generally sells products with a limited warranty of product quality and a limited indemnification of customers against intellectual property infringement claims related to the Company’s products. The Company accrues for known warranty and indemnification issues if a loss is probable and can be reasonably estimated, and accrues for estimated incurred but unidentified issues based on historical activity. As of December 27, 2008 and December 29, 2007, the Company had warranty reserves of $1.3 million and $1.0 million, respectively. For the fiscal years 2008, 2007 and 2006 warranty expense was approximately $1.5 million, $0.6 million and $0.4 million, respectively.

Asset Retirement Obligations

The Company recorded assets and asset retirement obligations (ARO) liabilities of $0.9 million and $0.8 million at December 27, 2008 and December 29, 2007, respectively, which represents the legal obligations associated with retirement of their assets when the timing and/or method of settling the obligation are conditional on a future event that may or may not be within the control of the Company. The Company also recorded accumulated depreciation charges of $0.5 million and $0.5 million, at December 27, 2008 and December 29, 2007, respectively, which represents the cumulative amortization of the capitalized long-lived asset associated with this obligation. The Company estimated the ARO using a discounted cash flow model that considered the Company’s cost of capital as well as increases in costs prior to settlement of the obligations and considered the probability that performance would be required.

 

     2008

Beginning balance as of December 29, 2007

   $ 805,797

Additions liabilities incurred

     25,000

Payment to settle liabilities

     —  

Accretion

     36,168
      

Ending balance as of December 27, 2008

   $ 866,965
      

Income Taxes

The consolidated financial statements reflect provisions for federal, state, local and foreign income taxes. The Company recognizes deferred tax assets and liabilities for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis, as well as operating loss and tax credit carryforwards. The Company measures deferred tax assets and liabilities using enacted tax rates expected to apply to taxable income in the years in which those temporary differences and carryforwards are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company provides valuation allowances if, based on the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized.

There are no known tax positions which are reasonably possible to change over the next twelve months necessitating a significant change in our unrecognized tax benefits.

The Company recognized interest and penalties related to unrecognized tax benefits in income tax expense in the consolidated statements of operations.

Foreign Currency

Assets and liabilities of non-U.S. operations where the functional currency is other than the U.S. dollar are translated from the functional currency into U.S. dollars at year end exchange rates, and revenues and expenses at average rates prevailing during the year. Resulting translation adjustments are accumulated as part of accumulated other comprehensive income. Transaction gains or losses are recognized in income or loss in the period in which they occur.


KOPIN CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

Net Income (Loss) Per Share

Basic net income (loss) per share is computed using the weighted average number of shares of common stock outstanding during the period less any unvested restricted shares. Diluted earnings per common share is calculated using weighted-average shares outstanding and contingently issuable shares, less weighted-average shares reacquired during the period. The net outstanding shares are adjusted for the dilutive effect of shares issuable upon the assumed conversion of the Company’s common stock equivalents, which consist of outstanding stock options and unvested restricted stock units.

Weighted average common shares outstanding used to calculate earnings per share, is as follows:

 

     2008    2007    2006

Weighted average common shares outstanding—basic

   67,876,385    67,543,957    68,064,262

Stock options and nonvested restricted common stock

   287,374    —      —  
              

Weighted average common shares outstanding—diluted

   68,163,759    67,543,957    68,064,262
              

The following were not included in weighted average common shares outstanding- diluted because they are anti-dilutive.

 

     2008    2007    2006

Nonvested restricted common stock

   886,324    578,512    883,250

Stock options

   5,823,032    6,858,322    8,229,749
              

Total

   6,709,356    7,436,834    9,112,999
              

Concentration of Credit Risk

The Company primarily invests its excess cash in government backed and corporate financial instruments management believes to be of high credit worthiness, which bear lower levels of relative credit risk. The Company relies on rating agencies to ascertain the credit worthiness of its marketable securities and, where applicable, guarantees by the Federal Deposit Insurance Company. The Company sells its products to customers worldwide and generally does not require collateral. The Company maintains a reserve for potential credit losses.

Fair Value of Financial Instruments

Financial instruments consist of current assets (except inventories, income tax receivables and prepaid assets) and certain current liabilities. Current assets and current liabilities are carried at cost, which approximates fair value.

Stock-Based Compensation

The fair value of an option grant is estimated on the date of grant using the Black-Scholes-Merton option-pricing. There were no stock options granted in fiscal years 2008, 2007 and 2006.

Comprehensive (Loss) Income

Comprehensive (loss) income is the total of net income (loss) and all other non-owner changes in equity including such items as unrealized holding gains (losses) on marketable equity and debt securities classified as available-for-sale and foreign currency translation adjustments.

The components of accumulated other comprehensive (loss) income is as follows:

 

     Cumulative
Translation
Adjustment
    Unrealized Holding
(Loss) Gain on
Marketable
Securities
    Accumulated Other
Comprehensive
Income (Loss)
 

Balance as of December 25, 2005

   $ 2,514,660      $ (392,419   $ 2,122,241   

Changes during year

     1,164,486        (341,629     822,857   
                        

Balance as of December 30, 2006

     3,679,146        (734,048     2,945,098   

Changes during year

     289,826        532,332        822,158   
                        

Balance as of December 29, 2007

   $ 3,968,972      $ (201,716   $ 3,767,256   

Changes during year

     (4,735,054     799,495        (3,935,559
                        

Balance as of December 27, 2008

   $ (766,082   $ 597,779      $ (168,303
                        


KOPIN CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

Impairment Charge

In accordance with Statement of Financial Accounting Standards (SFAS) No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets, the Company periodically reviews the carrying value of our long-lived assets to determine if facts and circumstances suggest that they may be impaired or that the amortization or depreciation period may need to be changed. The carrying value of a long-lived asset is considered impaired when the anticipated identifiable undiscounted cash flows from such asset are less than its carrying value. For assets that are to be held and used, impairment is measured based upon the amount by which the carrying amount of the asset exceeds its fair value. The carrying value of the Company’s long-lived assets was $19.4 million at December 27, 2008.

Recently Adopted Accounting Pronouncements

In September 2006, the Financial Accounting Standards Board (FASB) issued SFAS No. 157, “Fair Value Measurements” (SFAS 157) which enhances existing guidance for measuring assets and liabilities at fair value. SFAS 157 defines fair value, establishes a framework for measuring fair value and expands disclosure about fair value measurements. The Company adopted SFAS No. 157 on January 1, 2008, as required for its financial assets and financial liabilities. However, the FASB deferred the effective date of SFAS 157 for one year as it relates to fair value measurement requirements for nonfinancial assets and nonfinancial liabilities that are not recognized or disclosed at fair value on a recurring basis. The adoption of SFAS 157 for the Company’s financial assets and financial liabilities did not have a material impact on its consolidated financial statements (See Note 4).

In February 2007, the FASB issued SFAS No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities” (SFAS 159). SFAS 159 permits an entity to choose, at specified election dates, to measure eligible financial instruments and certain other items at fair value that are not currently required to be measured at fair value. An entity shall report unrealized gains and losses on items for which the fair value option has been elected in earnings at each subsequent reporting date. Upfront costs and fees related to items for which the fair value option is elected shall be recognized in earnings as incurred and not deferred. SFAS 159 also establishes presentation and disclosure requirements designed to facilitate comparisons between entities that choose different measurement attributes for similar types of assets and liabilities. SFAS 159 is effective for financial statements issued for fiscal years beginning after November 15, 2007 and interim periods with those financial years. At the effective date, an entity may elect the fair value option for eligible items that exist at that date. The entity shall report the effect of the first remeasurement to fair value as a cumulative-effect adjustment to the opening balance of retained earnings. The Company did not elect the fair value option for any of its eligible items as of December 29, 2007.

In December 2007, the FASB issued SFAS No. 160, Noncontrolling Interests in Consolidated Financial Statements (SFAS 160). SFAS 160 amends Accounting Research Bulletin No. 51, Consolidated Financial Statements, to establish accounting and reporting standards for the noncontrolling interest in a subsidiary and for the deconsolidation of a subsidiary. The Company adopted SFAS 160 on December 28, 2008, the first day of its 2009 fiscal year and retrospectively applied the standard for all periods presented.

Accounting Pronouncements to be Adopted

In December 2007, the Financial Accounting Standards Board (FASB) issued SFAS No. 141(R), Business Combinations (SFAS 141(R)). SFAS 141(R) requires an acquirer to recognize the assets acquired, the liabilities assumed, and any noncontrolling interest in the acquiree at the acquisition date, measured at their fair values as of that date. It requires acquisition-related costs and restructuring costs that the acquirer expects but is not obligated to incur to be recognized separately from the acquisition. SFAS No. 141(R) modifies the criteria for the recognition of contingencies as of the acquisition date. It also provides guidance on subsequent accounting for acquired contingencies. SFAS No. 141(R) is effective for business acquisitions for which the acquisition date is on or after January 1, 2009. SFAS 141(R) will not impact the Company’s accounting for prior acquisitions.

In March 2008, the FASB issued SFAS No. 161,“Disclosures about Derivative Instruments and Hedging Activities—an amendment of FASB Statement No. 133” (SFAS 161). SFAS 161 amends FASB Statement No. 133 to require enhanced disclosures about an entity’s derivative and hedging activities thereby improving the transparency of financial reporting. Entities are required to provide enhanced disclosures about (a) how and why an entity uses derivative instruments, (b) how derivative instruments and related hedged items are accounted for under Statement 133 and its related interpretations, and (c) how derivative instruments and related hedged items affect an entity’s financial position, financial performance, and cash flows. This Statement is effective for financial statements issued for fiscal years and interim periods beginning after November 15, 2008. The Company does not currently hold any positions in derivative instruments or participate in hedging activities and thus does not expect the adoption of SFAS 161 to have any impact on its results of operations or financial position.


KOPIN CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

2. Property, Plant and Equipment

Property, plant and equipment consisted of the following at December 27, 2008 and December 29, 2007:

 

     Useful Life    2008     2007  

Land

      $ 760,269      $ 1,027,585   

Buildings

   10 years      2,135,036        2,875,584   

Equipment

   3-5 years      41,451,287        36,050,507   

Leasehold improvements

   Life of the lease      13,882,281        11,957,334   

Furniture and fixtures

   3 years      360,724        328,317   

Equipment under construction

        1,391,661        6,241,137   
                   
        59,981,258        58,480,464   

Accumulated depreciation and amortization

        (40,621,384     (36,553,403
                   
      $ 19,359,874      $ 21,927,061   
                   

During fiscal 2007 the Company recognized losses on disposal of equipment of $453,000. There were no gains or losses on disposals of long-lived assets in fiscal years 2008 and 2006. Depreciation expense for the fiscal years 2008, 2007 and 2006 was approximately $5,035,000, $3,457,000 and $2,623,000 respectively.

 

3. Other Assets and Amounts Due To / Due From Affiliates

Other assets consist of the following as of December 27, 2008 and December 29, 2007:

 

     2008    2007

Marketable Equity Security

     

Micrel Inc.

   $ 1,464,892    $ 1,689,171

Non-Marketable Equity Securities

     

Equity Method Securities

     

KTC

     —        —  

KoBrite

     3,639,638      3,896,567

Cost Method Securities

     

Kenet

     —        5,395,905

AWSC

     774,588      774,588

Other

     181,342      224,942
             
   $ 6,060,460    $ 11,981,173
             

Marketable Equity Security

As of December 27, 2008 and December 29, 2007, the Company held approximately 200,000 shares of Micrel common stock with an adjusted cost basis of approximately $1.5 million and $1.7 million, respectively. The adjusted cost basis reflects a $0.2 million and $0.1 million other-than-temporary charge to the statement of operations to reduce the carrying value to fair market value at December 27, 2008 and December 29, 2007, respectively. This investment is considered to be an available-for-sale security and, accordingly, the investment is carried on the consolidated statement of financial position at fair market value and unrealized gains and losses resulting from the difference between its adjusted cost and fair market value are recorded in other comprehensive income. In 2006, the Company sold 200,000 shares of Micrel common stock for approximately $3.0 million and recognized a gain of approximately $1.2 million, which is presented in the consolidated statement of operations.

Non-Marketable Securities—Equity Method Investments

Equity losses in unconsolidated affiliates consisted of the following:

 

     2008     2007     2006  

KTC

   $ (824,276   $ —        $ —     

KoBrite

     (256,929     (274,577     (593,911
                        

Total

   $ (1,081,205   $ (274,577   $ (593,911
                        

At December 27, 2008, the Company has an approximate 40% interest in Kopin Taiwan Corp (KTC), which is accounted for using the equity method and had a carrying value of $0. The Company has manufactured products for KTC to sell to its customers and


KOPIN CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

sells raw substrates to KTC. Also, KTC manufactures products for the Company to sell to its customers. The Company is not required to provide additional financing to KTC. However, during 2008 KTC experienced liquidity issues and the Company loaned KTC $2.0 million. At December 27, 2008 the Company reviewed the collectability of the loan and recorded a loan loss reserve of $1.2 million. In addition, under EITF 98-13 Accounting by an Equity Method Investor for Investee Losses When the Investor Has Loans to and Investments in Other Securities of the Investee the Company resumed the equity method of accounting and as a result recorded equity losses of $0.8 million in 2008.

As a result of the transactions between Kopin and KTC each party normally has accounts receivable and accounts payable from and to the other party. In 2008 the Company recorded $0.5 million of allowance for doubtful accounts representing the net difference between the amounts the Company was owed from KTC for trade accounts receivables and the amounts the Company owed KTC for trade accounts payables at December 27, 2008. The following is a summary of amounts recorded in our statement of operations for the fiscal years indicated for other than purchases and sales of products:

 

     2008    2007    2006

Equity losses recorded

   $ 824,276    $ —      $ —  

Loans written-off

     1,187,937      —        —  

Reserves for bad debts

     506,762      —        —  
                    

Total

   $ 2,518,975    $ —      $ —  
                    

One of the Company’s Directors is chairman of KTC and owns approximately 1% of the outstanding common stock of KTC.

The Company has accumulated an approximate 28% interest in KoBrite at December 27, 2008. The Company accounts for its interest using the equity method and at December 27, 2008 the carrying value of the investment was $3.6 million. KoBrite’s results are recorded one quarter in arrears. For fiscal years 2008, 2007 and 2006 the Company recorded losses of $0.3 million, $0.3 million and $0.6 million, respectively, in equity losses in unconsolidated affiliates in the consolidated statement of operations. Subsequent to December 27, 2008 KoBrite began the process of raising additional capital. In 2009, a current investor in KoBrite agreed to purchase equity shares from KoBrite. The share purchase is at KoBrite’s net book value. Accordingly, there is no impairment indicator. The Company has declined to participate, and if the sale of common stock is completed the Company’s ownership of KoBrite will decline to approximately 19%. In June 2008, one of the Company’s Directors, who is also the chairman of KTC, was elected to the Board of Directors of Bright LED, one of the principle investors of KoBrite.

Summarized financial information for KTC for the year ended December 31, and for KoBrite for the year ended September 30, is as follows:

 

     2008     2007     2006  

Current assets

   $ 11,746,000      $ 16,845,000      $ 15,548,000   

Non current assets

     22,878,000        26,232,000        26,863,000   

Current liabilities

     7,986,000        8,896,000        6,839,000   

Non current liabilities

     —          615,000        1,227,000   

Revenues

     14,611,000        13,744,000        5,715,000   

Margin income (loss)

     (1,024,000     1,007,000        (1,766,000

Loss from operations

     (4,340,000     (1,602,000     (6,018,000

Net loss

   $ (4,651,000   $ (1,900,000   $ (5,937,000

Non-Marketable Securities—Cost Method Investments

At December 27, 2008 the Company had an investment in Advance Wireless Semiconductor Company (AWSC), with a carrying value of $0.8 million, which the Company accounts for on the cost basis. One of the Company’s Directors is a director of AWSC and several directors and officers own amounts ranging from 0.1% to 0.5% of the outstanding stock of AWSC.

On October 3, 2008 all of the outstanding common stock and assets of Kenet were sold. The Company’s portion of the net proceeds totaled $4.2 million. The cost basis of the investment was $6.9 million at the date of sale. The Company recorded a loss on the sale of $2.7 million. The acquisition agreement also provides for former shareholders of Kenet to earn additional proceeds based on the sales of Kenet products during the period January 3, 2009 until July 3, 2010. The Company could earn up to approximately $2.0 million. The amount will not be recorded until received.

Our Chief Executive Officer was a founder and board member of Kenet and owned approximately 2.3%. Certain of our directors and an officer had also invested in Kenet and their ownership ranged from 0.1% to 1.0%.


KOPIN CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

Amounts Due from and Due to Affiliates

Related party receivables at December 27, 2008 and December 29, 2007 approximate the following amounts:

 

     December 27,
2008
   December 29,
2007

Advanced Wireless Semiconductor

   $ 1,821,000    $ 1,686,000

KTC

     993,000      1,935,000
             

Accounts receivable from unconsolidated affiliates

   $ 2,814,000    $ 3,621,000
             

Related party payables at December 27, 2008 and December 29, 2007 approximate the following amounts:

 

     December 27,
2008
   December 29,
2007

KTC

   $ 993,000    $ 2,084,000
             

Accounts payable to unconsolidated affiliates

   $ 993,000    $ 2,084,000
             

The table below shows amounts sold by the Company (revenues), and amounts purchased by the Company (purchases) from the indicated affiliate:

 

     2008    2007    2006
     Revenues    Purchases    Revenues    Purchases    Revenues    Purchases

KTC

   $ 1,700    $ 3,872,000    $ 3,000    $ 4,490,000    $ 39,000    $ 1,844,000

KoBrite

     —        —        —        —        850,000      —  

Advanced Wireless Semiconductor

     12,461,000      —        7,341,000      —        10,065,000      —  
                                         

Total

   $ 12,462,700    $ 3,872,000    $ 7,344,000    $ 4,490,000    $ 10,954,000    $ 1,844,000
                                         

Certain officers and directors have invested in some of the Company’s investee companies, including Micrel. The Company has a loan to a non-officer employee for approximately $170,000 at December 27, 2008, which is due in 2009.

 

4. Fair Value Measurements

On December 30, 2007, the Company adopted SFAS No. 157 “Fair Value Measurements” (SFAS 157). This statement defines fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements. Under SFAS 157 the fair value of investments are categorized by the method by which their fair value is computed. The three categories are defined as Level 1, Level 2 and Level 3. An investment is categorized as Level 1 when its fair value is based on unadjusted quoted prices in active markets for identical assets that the Company has the ability to access at the measurement date. An investment is categorized as Level 2 if its fair market value is based on quoted market prices for similar assets in active markets, quoted prices for identical or similar assets in markets that are not active, based on observable inputs such as interest rates, yield curves, or derived from or corroborated by observable market data by correlation or other means. An investment is categorized as Level 3 if its fair value is based on assumptions developed by the Company about what a market participant would use in pricing the assets.

The following table details the fair value measurements within the fair value hierarchy of the Company’s financial assets:

 

          Fair Value Measurement at December 27, 2008 Using:
                Level 1                Level 2                Level 3      

U.S. Government Securities

   $ 25,887,362    $ 25,887,362    $ —      $ —  

Corporate Debt

     16,179,180      —        16,179,180      —  

Micrel, Inc.

     1,464,892      1,464,892      —        —  
                           
   $ 43,531,434    $ 27,352,254    $ 16,179,180    $ —  
                           


KOPIN CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

5. Stockholders’ Equity and Stock-Based Compensation

The Company had an ongoing authorization, as amended, through 2006 from the Board of Directors to repurchase the Company’s common stock in open market or negotiated transactions. As of December 27, 2008, the Company had repurchased 3,563,200 shares of its common stock for $14,275,139. In December 2008, the Company’s Board of Directors approved an additional share repurchase program, authorizing the Company to purchase up to $15 million of its common stock.

The Company has stock-based awards outstanding under several plans. The Company’s 1992 Stock Option Plan (the 1992 Plan), which expired on December 31, 2001, permitted the granting of both nonqualified stock options and incentive stock options and authorized 15,000,000 shares of common stock (including shares issued upon exercise of options granted pursuant to the Company’s 1985 Stock Option Plan). In 2001, the Company adopted a 2001 Equity Incentive Plan (the Equity Plan) and a 2001 Supplemental Equity Plan (the Supplemental Plan). The Equity Plan was approved by shareholders and the Supplemental Plan was approved by the Board of Directors of the Company. The Equity Plan, as amended, permits the granting of both nonqualified and incentive stock options and restricted stock awards. The Equity Plan authorized 5,350,000 shares of common stock, which may be issued to employees, non-employees, and members of the Board of Directors (the Board). The Supplemental Plan authorized 1,300,000 shares of common stock, which may be issued to employees and only permits the issuance of nonqualified stock options and restricted common stock awards. The option price of incentive stock options shall not be less than 100% of the fair market value of the stock at the date of grant, or in the case of certain incentive stock options, at 110% of the fair market value at the time of the grant. The option price of nonqualified stock options is determined by the Board or Compensation Committee. Options must be exercised within a ten-year period or sooner if so specified within the option agreement. The term and vesting period for restricted stock awards and options granted under the Equity Plan and the Supplemental Plan are determined by the Board’s compensation committee. Nonvested stock awards and options granted generally vest over either two or four year service periods, although the vesting of some awards may accelerate if certain conditions are met.

The Company has available approximately 500,000 shares of common stock for issuance under the Company’s stock award plans.

Stock Options

A summary of award activity under the stock option plans as of December 27, 2008 and changes during the twelve month period is as follows:

 

     2008
     Shares     Weighted
Average
Exercise
Price

Balance, beginning of year

   6,858,322      $ 11.69

Options granted

   —          —  

Options forfeited/cancelled

   (988,737     11.18

Options exercised

   (44,053     2.98
        

Balance, end of year

   5,825,532      $ 11.68
        

Exercisable, end of year

   5,794,157     
        

The following table summarizes information about stock options outstanding and exercisable at December 27, 2008:

 

     Options Outstanding    Options Exercisable

Range of Exercise Prices

   Number
Outstanding
   Weighted
Average
Remaining
Contractual
Life (Years)
   Weighted
Average
Exercise
Price
   Number
Exercisable
   Weighted
Average
Exercise
Price

$  0.01—$  3.55

     146,500    6.41    $ 3.43      115,250    $ 3.41

$  3.75—$  4.97

     1,276,682    4.41      4.46      1,276,557      4.46

$  5.00—$  9.95

     1,288,436    3.82      6.03      1,288,436      6.03

$10.00—$13.00

     1,475,170    2.36      11.28      1,475,170      11.28

$14.31—$44.88

     1,638,744    1.63      22.84      1,638,744      22.84
                      
     5,825,532    3.03    $ 11.68      5,794,157    $ 11.72
                      

Aggregate intrinsic value on December 27, 2008

   $ 5,250          $ 5,250   
                      


KOPIN CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

A summary of options vested and expected to vest at December 27, 2008 is as follows:

 

     Shares    Weighted
Average
Exercise
Price
   Aggregate
Intrinsic
Value

Options vested at year end

   5,794,157    $ 11.72    $ 5,250

Options expected to vest, at year end

   31,375      3.50      —  
              

Options vested and expected to vest

   5,825,532    $ 11.68    $ 5,250
              

No stock options were issued in 2008, 2007 or 2006. The intrinsic value of options exercised in 2008, 2007 and 2006 was approximately $7,000, $87,000 and $162,000, respectively.

Cash received from option exercises under all share-based payment arrangements was approximately $0.1 million and $0.3 million for fiscal years 2008 and 2007, respectively. No tax benefits were realized during this period due to the existence of tax net operating loss carryforwards.

In fiscal year 2008 the Company purchased and cancelled under a tender offer 197,218 stock options held by employees. Had these stock options not been purchased by the Company they may have resulted in excise taxes for the employees and reporting requirements for the Company under section 409 (A) of the Internal Revenue Code. The Company paid approximately $180,000 for these stock options which represented the fair market value of the options as determined through the use of the Black-Scholes-Merton option pricing model.

NonVested Restricted Common Stock

The Company has issued shares of nonvested restricted common stock to certain employees. Each award requires the employee to fulfill certain obligations, including remaining employed by the Company for one, two or four years (the vesting period) and in certain cases meeting performance criteria. A summary of the activity for nonvested restricted common stock awards as of December 27, 2008 and changes during the twelve months then ended is presented below:

 

     Shares     Weighted
Average
Grant
Fair Value

Balance December 29, 2007

   578,512      $ 3.86

Granted

   1,783,207        2.55

Forfeited

   (453,633     2.75

Vested

   (633,571     3.40
        

Balance, December 27, 2008

   1,274,515      $ 2.65
        

Stock-Based Compensation

The following table summarizes stock-based compensation expense related to employee stock options and nonvested restricted common stock awards under SFAS123R for the fiscal years 2008, 2007 and 2006 (no tax benefits were recognized):

 

     2008    2007    2006

Cost of product revenues

   $ 715,056    $ 581,808    $ 511,738

Research and development

     441,080      244,598      294,702

Selling, general and administrative

     1,584,713      1,428,150      1,983,218
                    

Total

   $ 2,740,849    $ 2,254,556    $ 2,789,658
                    

The total unrecognized compensation cost related to nonvested restricted common stock awards is expected to be recognized over a weighted average period of 2 years. The total unrecognized compensation cost is as follows at December 27, 2008:

 

     2008

Stock option awards

   $ 24,953

Nonvested restricted common stock awards

     2,567,546
      
   $ 2,592,499
      


KOPIN CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

6. Concentrations of Risk

Financial instruments that potentially subject the Company to concentration of credit risk other than marketable securities consist principally of trade accounts receivable. Trade receivables are primarily derived from sales to manufacturers of consumer electronic devices and wireless components or military applications. Ongoing credit evaluations of customers’ financial condition are performed and collateral, such as letters of credit, are generally not required. The following table depicts the customer’s trade receivable balance as a percentage of gross trade receivables as of the end of the year indicated: (The symbol “*” indicates that the customer’s accounts receivable balance was less than 10% of the Company’s Gross Accounts Receivables):

 

     Percent of Gross Accounts Receivable  

Customer

   2008     2007  

Skyworks Solutions, Inc.

   14   17

Advanced Wireless Semiconductor Co.

   11      10   

DRS Technologies

   19      12   

KTC

   *      11   

QiOptiq

   12      *   

Sales to significant non-affiliated customers, for fiscal years 2008, 2007 and 2006, as a percentage of total revenues were as follows: (The symbol “*” indicates that sales to that customer were less than 10% of the Company’s total revenues.)

 

     Sales as a Percent
of Total Revenue
 
     Fiscal Year  

Customer

   2008     2007     2006  

Skyworks Solutions, Inc.

   20   26   36

Advanced Wireless Semiconductor Company

   9      5      13   

Military Customers

   32      16      16   

United States Government Funded Research and Development Contracts

   6      4      7   

DRS Technologies

   19      *      10   

Sanyo Electric Co, Ltd.

   *      16      *   

Skyworks Solutions, Inc. (Skyworks Solutions) also uses the foundry services of Advanced Wireless Semiconductor Company (AWSC) to process the Company’s HBT transistor wafers on their behalf. In 2005, the Company began selling HBT transistor wafers directly to AWSC for eventual resale by AWSC to Skyworks Solutions. AWSC also purchases HBT transistor wafers from the Company for the processing and sale to other customers. Sales to DRS Technologies are included within the Military Customers category. Removing DRS Technologies would reduce sales to Military Customers to 13%.

 

7. Income Taxes

The provision (benefit) for income taxes consists of the following for the fiscal years indicated:

 

     Fiscal Year  
     2008     2007     2006  

Current

      

Federal

   $ 181,000      $ —        $ 1,807,000   

State

     158,000        43,000        53,000   

Foreign

     453,000        422,000        (505,000

Expiration of tax contingencies

     —          —          (300,000

Deferred

      

Federal

     736,000        (1,756,000     (2,034,000

State

     1,627,000        (469,000     (178,000

Foreign

     364,000        (10,000     (5,000

Tax credits

     —          —          (102,000

Change in valuation allowance

     (2,727,000     2,235,000        991,000   
                        
   $ 792,000      $ 465,000      $ (273,000
                        


KOPIN CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

Net operating losses utilized in 2008 and 2006 to offset federal and state taxes were $3,527,000 and $1,713,000, respectively.

The actual income tax provision (benefit) reported from operations are different than those which would have been computed by applying the federal statutory tax rate to loss before income tax benefit. A reconciliation of income tax benefit as computed at the U.S. federal statutory income tax rate to the provision for income tax benefit is as follows:

 

     Fiscal Year  
     2008     2007     2006  

Tax provision (benefit) at U.S. statutory rates

   $ 1,127,000      $ (1,926,000   $ (816,000

State tax liability (benefit)

     1,730,000        (441,000     —     

Foreign tax rate difference

     (228,000     (259,000     (263,000

Nondeductible expenses

     56,000        4,000        98,000   

Utilized/expired net state operating loss carryforwards

     (862,000     990,000        —     

State tax rate change

     1,039,000        (1,845,000     —     

(Increase) Reduction of credits

     (348,000     686,000        —     

Non-deductible equity compensation

     1,272,000        1,021,000        —     

Expiration of Contingencies

     —          —          (300,000

Other, net

     (267,000     —          17,000   

Change in valuation allowance

     (2,727,000     2,235,000        991,000   
                        
   $ 792,000      $ 465,000      $ (273,000
                        

State operating losses must be offset against taxable income within 5 years of the incurrence of the losses. In 2007 approximately $33.0 million of state operating losses expired unused. The Company decreased its state tax rate from 6% for 2007 to 4% for 2008. The Company determines its domestic state tax rate by allocating its results of operations and other factors to the various states it has operations in and applying the state’s applicable tax rates.

Pretax foreign earnings (losses) were approximately $3,669,000, $1,946,000 and ($746,000) for the fiscal years 2008, 2007 and 2006, respectively. The Company has not received any remittance of any earnings from its foreign operations nor does it intend to in the foreseeable future. Accordingly, U.S. income taxes were not provided for approximately $10.9 million of undistributed earnings of the Company’s Korean subsidiary.

Deferred taxes are provided to recognize the effect of temporary differences between tax and financial reporting. Deferred income tax assets and liabilities consist of the following:

 

     Fiscal Year  
     2008     2007  

Deferred tax assets:

    

Federal net operating loss carryforwards

   $ 15,662,000      $ 18,333,000   

State net operating loss carryforwards

     162,000        1,024,000   

Equity awards

     7,183,000        8,488,000   

Tax credits

     3,820,000        3,391,000   

Equipment

     3,540,000        3,772,000   

Investments

     5,550,000        4,874,000   

Other

     8,333,000        7,095,000   
                

Net deferred tax assets

     44,250,000        46,977,000   

Valuation allowance

     (44,250,000     (46,977,000
                
   $ —        $ —     
                

As of December 27, 2008, the Company has available for tax purposes federal net operating loss carryforwards (NOL) of $44.7 million expiring through 2026. The Company also has a state NOL of $27.2 million. As a result of recent tax legislation changes, the availability of the state NOL may be limited in future periods. The Company has not historically recorded, nor does it intend to record the tax benefits from stock awards until realized. Unrecorded benefits from stock awards approximated $14.5 million at each of the years ended 2008 and 2007. The Company has recognized a full valuation allowance on its net deferred tax assets due to the uncertainty of realization of such assets. The change in the valuation allowance during 2008 was due to an increase in deferred tax assets of $800,000 and the utilization of NOLs of $3,527,000.


KOPIN CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

The Company has unrecognized tax benefits of approximately $200,000 related to uncertainties regarding transfer pricing. These unrecognized tax benefits, if recognized, would affect the effective tax rate prior to the adjustment for the Company’s valuation allowance.

The Company’s Income Tax returns have not been examined by the Internal Revenue Service (the “IRS”) and are subject to examination for all years since 1992. State income tax returns are generally subject to examination for a period of 3 to 5 years after filing of the respective return. The state impact of any federal changes remains subject to examination by various states for a period of up to one year after formal notification to the states.

International jurisdictions have statutes of limitations generally ranging from 3 to 5 years after filing of the respective return. Years still open to examination by tax authorities in major jurisdictions include Korea (2003 onward), Japan (2003 onward) and Hong Kong (2005 onward). The Company is not currently under examination in these jurisdictions.

 

8. Accrued Warranty

The Company warrants its products against defect for 12 months. A provision for estimated future costs and estimated returns for credit relating to warranty is recorded in the period when product is shipped and revenue recognized, and is updated as additional information becomes available. The Company’s estimate of future costs to satisfy warranty obligations is based primarily on historical warranty expense experienced and a provision for potential future product failures. Changes in the accrued warranty for fiscal years 2008 and 2007 are as follows:

 

     Fiscal Year Ended  
     December 27,
2008
    December 29,
2007
 

Beginning Balance

   $ 1,030,000      $ 1,030,000   

Additions

     1,720,000        628,000   

Claim and reversals

     (1,500,000     (628,000
                

Ending Balance

   $ 1,250,000      $ 1,030,000   
                

 

9. Employee Benefit Plan

The Company has an employee benefit plan pursuant to Section 401(k) of the Internal Revenue Code of 1986, as amended. The plan allows employees to defer an amount of their annual compensation up to a current maximum of $15,500. The Company will match 50% of all deferred compensation up to a maximum of 3% of each employee’s annual compensation. The amount charged to operations in connection with this plan was approximately $192,000 $209,000 and $190,000 in fiscal years 2008, 2007 and 2006, respectively.

 

10. Commitments

Leases

The Company leases facilities located in Taunton and Westborough, Massachusetts, and Scotts Valley, California, under non-cancelable operating leases. The Taunton leases expire in 2012 and 2010. The Taunton lease which expires in 2010 may be extended for two additional 10 year periods. The Westborough lease expires in 2012. The Scotts Valley lease terminates in 2012. Substantially all real estate taxes, insurance and maintenance expenses under these leases are the Company’s obligations and are expensed as incurred and were immaterial. The following is a schedule of minimum rental commitments under non-cancelable operating leases at December 27, 2008:

 

Fiscal Year ending,

   Amount

2009

   $ 1,344,000

2010

     1,099,000

2011

     992,000

2012

     421,000

Thereafter

     —  
      

Total minimum lease payments

   $ 3,856,000
      

Amounts incurred under operating leases are recorded as rent expense on a straight line basis and aggregated approximately $1.5 million in fiscal years 2008, 2007 and 2006.


KOPIN CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

Other Agreements

The Company has entered into various license agreements which require payment of royalties based upon a set percentage of product sales, subject in some cases, to certain minimum amounts. Total royalty expense approximated $20,000, $15,000 and $27,000, respectively, in fiscal years 2008, 2007 and 2006.

In July 2008, the Company amended a purchase and supply agreement with a significant HBT customer that now expires in July 2010, excluding a last time buy option contained in the agreement. Under the terms of this agreement, the Company agreed to maintain capacity levels for manufacturing HBT wafers and the Company committed to a pricing schedule under certain circumstances. The agreement also requires the Company to give prior notice if the Company exits its HBT product line. In consideration for this agreement the customer agreed to source 100% of its HBT wafer needs from the Company subject to the customer’s right to source HBT wafers from other sources if the Company is unable to meet their requirements under certain circumstances. The Company agreed that failure to meet its supply obligations under the agreement would allow the Company’s customer to obtain court ordered specific performance and if the Company does not perform it could then be liable for monetary damages up to a maximum of $40.0 million. To date the Company has met its commitments under this agreement.

 

11. Litigation

The Company is engaged in legal proceedings arising in the ordinary course of business. Management believes the ultimate outcome of these proceedings will not have a material adverse impact on the Company’s consolidated financial position, results of operations or cash flows.

The Company has received a complaint from a customer who has made certain claims, including the claim that the Company violated an agreement which gave them an exclusivity to sell a product in a specific territory. They are seeking approximately $2.678 million Euros as compensation for expenses and damages. The Company does not believe the claim has merit and will vigorously defend against it.

 

12. Segments and Geographical Information

The Company’s chief operating decision maker is its Chief Executive Officer. The Company’s chief operating decision maker evaluates the operating results of the Company’s reportable segments based on revenues and net income (loss).

The Company has two operating and reportable segments, Kopin US, which includes the operations in the United States and the Company’s equity method investments, and Kowon. The following table presents the Company’s reportable segment results for the years ended December 27, 2008, December 29, 2007 and December 30, 2006:

 

     Kopin US     Kowon     Adjustments     Total  

2008

        

Revenues

   $ 109,236,000      $ 20,570,000      $ (15,000,000   $ 114,806,000   

Net income

     55,000        3,199,000        (668,000     2,586,000   

Total Assets

     147,276,000        19,213,000        (6,812,000     159,677,000   

2007

        

Revenues

   $ 92,621,000      $ 34,378,000      $ (28,850,000   $ 98,149,000   

Net (loss) income

     (7,767,000     1,532,000        (321,000     (6,556,000

Total Assets

     147,400,000        40,823,000        (27,169,000     161,054,000   

2006

        

Revenues

   $ 65,083,000      $ 8,945,000      $ (2,937,000   $ 71,091,000   

Net loss

     (1,404,000     (659,000     (86,000     (2,149,000

Total Assets

     146,177,000        21,534,000        (6,298,000     161,413,000   

The adjustments to reconcile to the consolidated financial statement total revenue, net (loss) income and total assets include the elimination of intercompany sales, noncontrolling interest in (income) loss of subsidiary and elimination of intercompany receivables.


KOPIN CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

Geographical revenue information for the three years ended December 27, 2008, December 29, 2007 and December 30, 2006 was based on the location of the customers and is as follows:

 

     Fiscal Year  
     2008     2007     2006  
     Revenue    % of Total     Revenue    % of Total     Revenue    % of Total  

Asia-Pacific

   $ 33,584,000    29   $ 40,451,000    41   $ 24,858,000    35

Americas

     81,222,000    71     57,698,000    59     46,233,000    65
                                       
   $ 114,806,000    100   $ 98,149,000    100   $ 71,091,000    100
                           

Revenues by product group consisted of approximately the following:

 

     Fiscal Year
     2008    2007    2006

III-V

   $ 47,011,000    $ 43,599,000    $ 43,931,000

Display

     67,795,000      54,550,000      27,160,000
                    

Total revenues

   $ 114,806,000    $ 98,149,000    $ 71,091,000
                    

Long-lived assets by geographic area are as follows:

 

     Fiscal Years
     2008    2007

United States of America

   $ 16,523,000    $ 17,972,000

Republic of Korea

     2,837,000      3,955,000
             
   $ 19,360,000    $ 21,927,000
             

 

13. Selected Quarterly Financial Information (Unaudited)

The following tables present Kopin’s quarterly operating results for the fiscal years ended December 27, 2008 and December 29, 2007. The information for each of these quarters is unaudited and has been prepared on the same basis as the audited consolidated financial statements. In the opinion of management, all necessary adjustments, consisting only of normal recurring adjustments, have been included to present fairly the unaudited consolidated quarterly results when read in conjunction with Kopin’s audited consolidated financial statements and related notes. These operating results are not necessarily indicative of the results of any future period.

Quarterly Periods During Fiscal Year Ended December 27, 2008:

 

     Three months
ended
March 29,
2008
   Three months
ended
June 28,
2008
    Three months
ended
September 27,
2008(1)
   Three months
ended
December 27,
2008(1)
     (In thousands, except per share data)

Revenue

   $ 29,165    $ 25,839      $ 30,709    $ 29,092

Gross profit(2)

     6,684      5,476        9,924      7,518

Net income (loss) attributable to the controlling interest

   $ 950    $ (1,674   $ 1,498    $ 1,812

Net income (loss) per share(3):

          

Basic

   $ 0.01    $ (0.02   $ 0.02    $ 0.03

Diluted

   $ 0.01    $ (0.02   $ 0.02    $ 0.03

Shares used in computing net income (loss) per share:

          

Basic

     67,742      67,732        67,774      68,258

Diluted

     67,747      67,732        68,528      68,648

 

(1) The net earnings for each of the third and fourth quarters of fiscal year 2008 were impacted by non cash charges of $2.5 million for the other than temporary impairment of certain assets.
(2) Gross profit is defined as net product revenue less cost of product revenues.
(3) Net income (loss) per share is computed independently for each of the quarters presented; accordingly, the sum of the quarterly net income per share may not equal the total computed for the year.


KOPIN CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

Quarterly Periods During Fiscal Year Ended December 29, 2007:

 

     Three months
ended
March 31,
2007
    Three months
ended
June 30,
2007
    Three months
ended
September 29,
2007
    Three months
ended
December 29,
2007(1)
     (In thousands, except per share data)

Revenue

   $ 18,129      $ 21,870      $ 29,221      $ 28,929

Gross profit(2)

     2,646        2,477        4,969        5,474

Net (loss) income attributable to the controlling interest

   $ (3,299   $ (3,152   $ (387   $ 282

Net (loss) income per share(3):

        

Basic

   $ (0.05   $ (0.05   $ (0.01   $ 0.00

Diluted

   $ (0.05   $ (0.05   $ (0.01   $ 0.00

Shares used in computing net (loss) income per share:

        

Basic

     67,468        67,526        67,547        67,634

Diluted

     67,468        67,526        67,547        67,650

 

(1) The net earnings for the fourth quarter of fiscal year 2007 was impacted by a non cash charge of $0.4 million for the writedown of assets and an increase in allowance for doubtful accounts of $0.5 million.
(2) Gross profit is defined as net product revenue less cost of product revenues.
(3) Net (loss) income per share is computed independently for each of the quarters presented; accordingly, the sum of the quarterly net income per share may not equal the total computed for the year.